| Anthony J Correnti, MD | |
|
764 2nd St # Sy, Manchester, NH 03102-5210 | |
| (603) 669-3925 | |
| (603) 669-0380 |
| Full Name | Anthony J Correnti |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 21 Years |
| Location | 764 2nd St # Sy, Manchester, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336261577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0107X | Ophthalmology - Retina Specialist | 14338 (New Hampshire) | Secondary |
| 207W00000X | Ophthalmology | 14338 (New Hampshire) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nh Eye Associates Pllc | 6608849823 | 12 |
News Archive
Revolutions Medical met with interested global distributors and showed, for the first time, the new market samples of its 3ml RevVac Safety syringe.
Athletes often have to compete late in the evening, when they are no longer able to perform at their best. As reported in the journal Frontiers in Physiology, however, researchers from the University of Basel have shown that athletes who are exposed to blue light before competing can significantly increase their performance in the final spurt.
Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.
Xencor, Inc., an antibody discovery and development company, announced today that it has entered into an antibody optimization collaboration with CSL, Ltd. The collaboration will provide CSL with access to Xencor's XmAb technology platform to enhance the ADCC effector function of its therapeutic antibodies.
The Medicare Payment Advisory Panel recommended this policy as a means to discourage overuse of home health services, which are estimated to cost taxpayers nearly $20 billion a year and are also a source of health care fraud. Meanwhile, another story, this one from WBUR, offers tips for Medicare "wellness" visits.
› Verified 7 days ago
| Entity Name | Elliot Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285627935 PECOS PAC ID: 6103727920 Enrollment ID: O20040115000634 |
News Archive
Revolutions Medical met with interested global distributors and showed, for the first time, the new market samples of its 3ml RevVac Safety syringe.
Athletes often have to compete late in the evening, when they are no longer able to perform at their best. As reported in the journal Frontiers in Physiology, however, researchers from the University of Basel have shown that athletes who are exposed to blue light before competing can significantly increase their performance in the final spurt.
Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.
Xencor, Inc., an antibody discovery and development company, announced today that it has entered into an antibody optimization collaboration with CSL, Ltd. The collaboration will provide CSL with access to Xencor's XmAb technology platform to enhance the ADCC effector function of its therapeutic antibodies.
The Medicare Payment Advisory Panel recommended this policy as a means to discourage overuse of home health services, which are estimated to cost taxpayers nearly $20 billion a year and are also a source of health care fraud. Meanwhile, another story, this one from WBUR, offers tips for Medicare "wellness" visits.
› Verified 7 days ago
| Entity Name | Nh Eye Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518044213 PECOS PAC ID: 6608849823 Enrollment ID: O20071001000644 |
News Archive
Revolutions Medical met with interested global distributors and showed, for the first time, the new market samples of its 3ml RevVac Safety syringe.
Athletes often have to compete late in the evening, when they are no longer able to perform at their best. As reported in the journal Frontiers in Physiology, however, researchers from the University of Basel have shown that athletes who are exposed to blue light before competing can significantly increase their performance in the final spurt.
Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.
Xencor, Inc., an antibody discovery and development company, announced today that it has entered into an antibody optimization collaboration with CSL, Ltd. The collaboration will provide CSL with access to Xencor's XmAb technology platform to enhance the ADCC effector function of its therapeutic antibodies.
The Medicare Payment Advisory Panel recommended this policy as a means to discourage overuse of home health services, which are estimated to cost taxpayers nearly $20 billion a year and are also a source of health care fraud. Meanwhile, another story, this one from WBUR, offers tips for Medicare "wellness" visits.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony J Correnti, MD 764 2nd St, Manchester, NH 03102-5210 Ph: (603) 669-3925 | Anthony J Correnti, MD 764 2nd St # Sy, Manchester, NH 03102-5210 Ph: (603) 669-3925 |
News Archive
Revolutions Medical met with interested global distributors and showed, for the first time, the new market samples of its 3ml RevVac Safety syringe.
Athletes often have to compete late in the evening, when they are no longer able to perform at their best. As reported in the journal Frontiers in Physiology, however, researchers from the University of Basel have shown that athletes who are exposed to blue light before competing can significantly increase their performance in the final spurt.
Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.
Xencor, Inc., an antibody discovery and development company, announced today that it has entered into an antibody optimization collaboration with CSL, Ltd. The collaboration will provide CSL with access to Xencor's XmAb technology platform to enhance the ADCC effector function of its therapeutic antibodies.
The Medicare Payment Advisory Panel recommended this policy as a means to discourage overuse of home health services, which are estimated to cost taxpayers nearly $20 billion a year and are also a source of health care fraud. Meanwhile, another story, this one from WBUR, offers tips for Medicare "wellness" visits.
› Verified 7 days ago
Ahad A Fazelat, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 250 River Rd, Manchester, NH 03104 Phone: 603-663-2020 Fax: 603-668-0881 | |
Jyotsom Bipin Ganatra, MD MPU Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 250 River Rd, Manchester, NH 03104 Phone: 603-668-2020 Fax: 603-668-0881 | |
Dr. Jason Alan Hall, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 250 River Rd, Manchester, NH 03104 Phone: 603-668-2020 Fax: 603-668-0881 | |
Melissa Mei Yiu Wong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 764 2nd St, Manchester, NH 03102 Phone: 603-669-3925 | |
Dr. Paul Michael Pender, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1415 Elm St, Nh Eye Associates Pa, Manchester, NH 03101 Phone: 603-669-3925 Fax: 603-669-0380 | |
David Allen Bellows, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 250 River Rd, Manchester, NH 03104 Phone: 603-668-2020 Fax: 603-668-0881 |